Blood-brain barrier disruption is more severe in neuromyelitis optica than in multiple sclerosis and correlates with clinical disability

Journal of International Medical Research

Volumn 40, Issue 4, 2012, Pages 1483-1491

  Tomizawa, Y ^a   Yokoyama, K ^a   Saiki, S ^a   Takahashi, T ^b   Matsuoka, J ^a   Hattori, N ^a  

^a JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Antiaquaporin 4 antibody; Blood brain barrier (BBB); Multiple sclerosis; Neuromyelitis optica; Neuromyelitis optica immunoglobulin G

Indexed keywords

AQUAPORIN 4 ANTIBODY; BIOLOGICAL MARKER; IMMUNOGLOBULIN G; SERUM ALBUMIN;

ADULT; ARTICLE; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIFFERENTIAL DIAGNOSIS; DISABILITY; DISEASE SEVERITY; EXPANDED DISABILITY STATUS SCALE; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; OBSERVATIONAL STUDY; PERMEABILITY BARRIER; PRINCIPAL COMPONENT ANALYSIS; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE;

EID: 84867511616     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/147323001204000427     Document Type: Article

References (26)

1. Lennon VA, Wingerchuk DM, Kryzer TJ, et al: A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis. Lancet 2004; 364: 2106 - 2112.
2. Lennon VA, Kryzer TJ, Pittock SJ, et al: IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005; 202: 473 - 477.
3. Vincent T, Saikali P, Cayrol R, et al: Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment. J Immunol 2008; 181: 5730 - 5737.
4. Bergamaschi R: Importance of cerebrospinal fluid examination in differential diagnosis of devic's neuromyelitis optica by multiple sclerosis. Neurol Sci 2003; 24: 95 - 96.
5. Wingerchuk DM, Lucchinetti CF: Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis. Curr Opin Neurol 2007; 20: 343 - 350.
6. Wingerchuk DM, Lennon VA, Pittock SJ, et al: Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485 - 1489.
7. Takahashi T, Fujihara K, Nakashima I, et al: Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: A study on antibody titre. Brain 2007; 130: 1235 - 1243.
8. Matsuoka T, Matsushita T, Kawano Y, et al: Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 2007; 130: 1206 - 1223.
9. Sellner J, Boggild M, Clanet M, et al: EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur J Neurol 2010; 17: 1019 - 1032.
10. Polman CH, Reingold SC, Edan G, et al: Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005; 58: 840 - 846.
11. Ohta M, Ohta K, Ma J, et al: Clinical and analytical evaluation of an enzyme immunoassay for myelin basic protein in cerebrospinal fluid. Clin Chem 2000; 46: 1326 1330.
12. Syndulko K, Tourtellotte WW, Conrad AJ, et al: Trans-blood-brain barrier albumin leakage and comparisons of intrathecal Igg synthesis calculations in multiple sclerosis patients. multiple sclerosis study group, alpha interferon study group, and azathioprine study group. J Neuroimmunol 1993; 46: 185 192.
13. Link H, Tibbling G: Principles of albumin and igg analyses in neurological disorders. iii. evaluation of igg synthesis within the central nervous system in multiple sclerosis. Scand J Clin Lab Invest 1977; 37: 397 - 401.
14. Brettschneider J, Claus A, Kassubek J, et al: Isolated blood-cerebrospinal fluid barrier dysfunction: Prevalence and associated diseases. J Neurol 2005; 252: 1067 - 1073.
15. Rapoport SI, Schapiro MB, May C: Reduced brain delivery of homovanillic acid to cerebrospinal fluid during human aging. Arch Neurol 2004; 61: 1721 - 1724.
16. Kurtzke JF: Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983; 33: 1444 1452.
17. Ghezzi A, Bergamaschi R, Martinelli V, et al: Clinical characteristics, course and prognosis of relapsing devic's neuromyelitis optica. J Neurol 2004; 251: 47 - 52.
18. Zaffaroni M, Italian devic's study group: Cerebrospinal fluid findings in devic's neuromyelitis optica. Neurol Sci 2004; 25( suppl 4): S368 - S370.
19. Jolliffe IT ( ed): Principal Component Analysis, 2nd edn. Berlin: Springer, 2002; pp 63 - 77.
20. Takano R, Misu T, Takahashi T, et al: Astrocytic damage is far more severe than demyelination in NMO: A clinical CSF biomarker study. Neurology 2010; 75: 208 - 216.
21. Hinson SR, McKeon A, Lennon VA: Neurological autoimmunity targeting aquaporin-4. Neuroscience 2010; 168: 1009 1018.
22. Tait MJ, Saadoun S, Bell BA, et al: Water movements in the brain: Role of aquaporins. Trends Neurosci 2008; 31: 37 - 43.
23. Wingerchuk DM, Weinshenker BG: Neuromyelitis optica. Curr Treat Options Neurol 2008; 10: 55 - 66.
24. Eichel R, Meiner Z, Abramsky O, et al: Acute disseminating encephalomyelitis in neuromyelitis optica: Closing the floodgates. Arch Neurol 2008; 65: 267 - 271.
25. Saiki S, Ueno Y, Moritani T, et al: Extensive hemispheric lesions with radiological evidence of blood-brain barrier integrity in a patient with neuromyelitis optica. J Neurol Sci 2009; 284: 217 - 219.
26. lto S, Mori M, Makino T, et al: "Cloud-like enhancement" is a magnetic resonance imaging abnormality specific to neuromyelitis optica. Ann Neurol 2009; 66: 425 - 428.